Jan 8 (Reuters) - Horizon Pharma Plc:
* HORIZON PHARMA PLC ANNOUNCES AGREEMENT TO LICENSE PRE-CLINICAL URICASE DERIVATIVE (MEDI4945) FROM MEDIMMUNE
* HORIZON PHARMA PLC - WILL PROVIDE MEDIMMUNE AN UPFRONT CASH PAYMENT AND FUTURE PAYMENTS CONTINGENT ON MEDI4945 DEVELOPMENT AND SALES MILESTONES Source text for Eikon: Further company coverage:
 